NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access
ID: 360554Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360554
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access." This initiative aims to provide researchers with access to biospecimens from significant studies, including the Adolescent Brain Cognitive Development (ABCD) Study and the HEALthy Brain and Child Development (HBCD) Study, to enhance understanding of the genetic and environmental factors influencing health and disease throughout life. The grant is open to a wide range of eligible applicants, including tribal governments, federal agencies, and foreign institutions, with no cost-sharing requirement. Interested parties should note that the estimated award date is January 4, 2027, and they can reach out to Heather L. Kimmel at heather.kimmel@nih.gov or by phone at 301-443-6504 for further information.

    Point(s) of Contact
    Heather L. Kimmel
    (301) 443-6504
    heather.kimmel@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal study of child health in the United States. This initiative, titled NIH Brain Development Cohorts (NBDC) Biospecimen Access, allows researchers to utilize biological samples such as blood, saliva, and hair to investigate the effects of environmental and biological factors on adolescent brain development and health. The program does not provide direct funding for research costs; applicants must secure their own funding and can apply for specific samples to enhance scientific understanding of adolescent health over a maximum project period of three years. Interested applicants can find more information and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with applications due by May 5, 2026.
    Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled the Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01), which invites researchers to apply for access to valuable biospecimens collected from an ongoing longitudinal study focused on tobacco use behaviors and health outcomes in the U.S. This initiative primarily provides urine, plasma, serum, and genomic DNA samples to support research relevant to tobacco regulations under the Family Smoking Prevention and Tobacco Control Act. The PATH Study, launched in 2011, plays a crucial role in advancing scientific understanding of tobacco use and its implications for public health. Applications will open on March 30, 2024, and close on October 31, 2026, with evaluations based on alignment with PATH objectives and the merit of proposed research. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study (Collaborative U01- Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the HEALthy Brain and Child Development (HBCD) Study, aimed at supporting research projects focused on participant recruitment, behavioral assessments, biospecimen collection, and neuroimaging. This initiative will involve a large cohort of approximately 7,200 pregnant women and their children, tracking their health and development over time, particularly in relation to exposure to various substances such as opioids and alcohol. The funding will be provided through a cooperative agreement, with an expected 27 awards available, and applications are anticipated to be solicited starting in July 2025, with a project start date set for July 1, 2026. For further inquiries, interested parties can contact Dr. Janani Prabhakar at janani.prabhakar@nih.gov or by phone at 301-827-4729.
    Adult-Adolescent Brain Cognitive Development (A-ABCD) Study Renewal-Research Project Sites (U01)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Adult-Adolescent Brain Cognitive Development (A-ABCD) Study, specifically for research project sites under the U01 cooperative agreement mechanism. This initiative aims to continue the groundbreaking ABCD study, which is the largest long-term investigation of brain development and child and adolescent health in the U.S., by following the original cohort of nearly 12,000 participants into their emerging adulthood to assess various health outcomes. The study utilizes advanced technologies, including brain scans and wearable sensors, to explore how young adult experiences influence brain development and related social and health outcomes. Interested organizations that were funded through RFA-DA-20-002 are encouraged to prepare for this opportunity, with the estimated synopsis posting date on February 6, 2026, and a projected award date of April 1, 2027. For further inquiries, potential applicants can contact Dr. Bethany Deeds at deedsb@nida.nih.gov or by phone at 301-402-1935.
    Adult-Adolescent Brain Cognitive Development (A-ABCD) Study Renewal-Data Analysis, Informatics and Resource Center, and Coordinating Center (U24)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Adult-Adolescent Brain Cognitive Development (A-ABCD) Study, specifically for the Data Analysis, Informatics and Resource Center, and the Coordinating Center. This initiative aims to continue the longitudinal study of brain development and health outcomes in a cohort of nearly 12,000 participants, following them from childhood into emerging adulthood to assess the impact of various factors on their development. The study utilizes advanced technologies, including brain scans and wearable sensors, to explore how experiences during young adulthood influence health and behavioral outcomes. Interested applicants, particularly existing awardees under RFA-DA-20-004 and RFA-DA-20-003, should note that applications are not currently being solicited, but they can prepare for future submissions. For further inquiries, contact Bethany Deeds, PhD, at deedsb@nida.nih.gov or by phone at 301-402-1935. The estimated synopsis post date is February 6, 2026, with a projected award date of April 1, 2027.
    Limited Competition for the HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study – Coordinating Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a limited competition opportunity for the HEAL Initiative, specifically for the Coordinating Administrative Core (HCAC) and the Data Coordinating Center (HDCC) for the HEALthy Brain and Child Development (HBCD) study. This initiative aims to support a large cohort study involving approximately 7,200 pregnant women and their children, focusing on the effects of prenatal exposure to various substances, including opioids and alcohol, on child development. The selected applicants will be responsible for coordinating data collection, processing, and analysis, as well as managing the consortium's operations, with applications expected to be solicited in the future. Interested parties can reach out to Dr. Janani Prabhakar at janani.prabhakar@nih.gov or by phone at 301-827-4729 for further information, with key deadlines including an estimated synopsis close date of October 17, 2025, and an estimated award date of July 1, 2026.
    Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants
    National Institutes of Health
    The National Institutes of Health (NIH) is offering exploratory grants under the Global Brain and Nervous System Disorders Research Across the Lifespan program, aimed at fostering collaborative neuro-health research between U.S. and low- and middle-income country (LMIC) organizations. The program encourages research across a wide spectrum of neuro-health issues, including neurological, neuropsychiatric, and neurodevelopmental diseases, with a focus on developing innovative and cost-effective interventions that address health needs both domestically and globally. Interested applicants, including Indian/Native American Tribal Governments and eligible agencies, must partner with at least one U.S. organization and one LMIC organization, with the estimated award date set for August 15, 2026. For further inquiries, potential applicants can contact UnJa Hayes at unja.hayes@nih.gov or by phone at 301-827-7024.
    Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Archiving and Documenting Child Health and Human Development Data Sets" under the R03 Small Grant Program. This initiative aims to support the archiving and documentation of existing data sets related to childhood health and human development, particularly those funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), to enhance data accessibility for secondary analysis by the scientific community. Eligible applicants include higher education institutions, nonprofits, and government entities, with funding available up to $50,000 for projects lasting a maximum of two years. Applications will be accepted starting January 16, 2025, with a submission deadline of February 16, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative to support clinical studies aimed at advancing next-generation devices for recording and modulation within the human central nervous system (CNS). This initiative encourages proposals for early-stage clinical investigations, including first-in-human studies, that focus on treating CNS disorders and enhancing understanding of brain functions, particularly through Significant Risk studies requiring FDA Investigational Device Exemptions (IDEs) for chronic implants. The NIH plans to allocate approximately $10 million annually to fund 5 to 7 projects, emphasizing the importance of collaborations with device manufacturers through a public-private partnership program, and requires a Plan for Enhancing Diverse Perspectives as part of the application. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with the application deadline set for January 28, 2027.